References

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statis tics, 1998. CA Cancer J Clin 1998;48:6-29.

2. Ries LAG, Miller BA, Hankey BF, et al., editors. SEER

Cancer Statistics Review, 1973-1991: tables and graphs. Bethesda (MD): National Cancer Institute; 1994 NIH Publication No.:94-2789.

3. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-52.

4. Wingo PA, Landis S, Ries LAG. An adjustment to the 1997

estimate for new prostate cancer cases. CA Cancer J Clin 1997;47:239-42.

5. Ries LAG, Kosary CL, Hankey BF, et al., editors. SEER

Cancer Statistics Review, 1973-1995. Bethesda (MD): National Cancer Institute; 1998 NIH Publication No.: 98-2789.

6. Stephenson RA. Population-based prostate cancer trends in the PSA era: data from the Surveillance, Epidemiology, and End Results (SEER) program. Monogr Urol 1998;19:3-19.

7. Mettlin CJ, Murphy GP. Why is the prostate cancer death rate declining in the United States? Cancer 1998;82: 249-51.

8. National Cancer Institute, SEER website, 1998; http:

//www-seer.ims.nci.nih.gov.

FIGURE 1-5. Estimated cancer deaths in 10 leading sites by gender, United States, 1998. Excludes basal and squamous cell skin cancer and carcinoma in situ except bladder. From Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1998. CA Cancer J Clin 1998;48:6-29.

Was this article helpful?

0 0

Post a comment